Phase 1 Relapsed Peripheral T-Cell Lymphoma Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedPeripheral T Cell LymphomaRelapsed Peripheral T-Cell Lymphoma+4 more

Mayo Clinic21 enrolled2 locationsNCT06508463

Recruiting

Phase 1Phase 2

Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas

Relapsed Peripheral T-Cell LymphomasRefractory Peripheral T-Cell Lymphomas

Navy General Hospital, Beijing52 enrolled1 locationNCT06176027